Stryker Corporation SYK.F Stock
Stryker Corporation Price Chart
Stryker Corporation SYK.F Financial and Trading Overview
Stryker Corporation stock price | 321.8 EUR |
Previous Close | 268.9 EUR |
Open | 269.1 EUR |
Bid | 0 EUR x 50000 |
Ask | 0 EUR x 50000 |
Day's Range | 269.1 - 270.7 EUR |
52 Week Range | 182.52 - 278.5 EUR |
Volume | 20 EUR |
Avg. Volume | 296 EUR |
Market Cap | 102.84B EUR |
Beta (5Y Monthly) | 0.95 |
PE Ratio (TTM) | 40.64565 |
EPS (TTM) | 7.69 EUR |
Forward Dividend & Yield | 2.74 (1.05%) |
Ex-Dividend Date | June 29, 2023 |
1y Target Est | 287.72 EUR |
SYK.F Valuation Measures
Enterprise Value | 115.02B EUR |
Trailing P/E | 40.64565 |
Forward P/E | 25.854824 |
PEG Ratio (5 yr expected) | 2.23 |
Price/Sales (ttm) | 5.426241 |
Price/Book (mrq) | 6.0823264 |
Enterprise Value/Revenue | 6.069 |
Enterprise Value/EBITDA | 24.746 |
Trading Information
Stryker Corporation Stock Price History
Beta (5Y Monthly) | 0.95 |
52-Week Change | 45.91% |
S&P500 52-Week Change | 20.43% |
52 Week High | 278.5 EUR |
52 Week Low | 182.52 EUR |
50-Day Moving Average | 262.49 EUR |
200-Day Moving Average | 237.97 EUR |
SYK.F Share Statistics
Avg. Volume (3 month) | 296 EUR |
Avg. Daily Volume (10-Days) | 181 EUR |
Shares Outstanding | 379.61M |
Float | 338.98M |
Short Ratio | N/A |
% Held by Insiders | 6.47% |
% Held by Institutions | 80.08% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 2.89 |
Trailing Annual Dividend Yield | 1.07% |
5 Year Average Dividend Yield | 106.00% |
Payout Ratio | 0.42069998 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 13.86% |
Operating Margin (ttm) | 19.17% |
Gross Margin | 62.91% |
EBITDA Margin | 24.52% |
Management Effectiveness
Return on Assets (ttm) | 6.22% |
Return on Equity (ttm) | 16.44% |
Income Statement
Revenue (ttm) | 18.95B EUR |
Revenue Per Share (ttm) | 50.07 EUR |
Quarterly Revenue Growth (yoy) | 11.79% |
Gross Profit (ttm) | 11.65B EUR |
EBITDA | 4.65B EUR |
Net Income Avi to Common (ttm) | 2.63B EUR |
Diluted EPS (ttm) | 6.66 |
Quarterly Earnings Growth (yoy) | 83.29% |
Balance Sheet
Total Cash (mrq) | 1.76B EUR |
Total Cash Per Share (mrq) | 4.63 EUR |
Total Debt (mrq) | 13.56B EUR |
Total Debt/Equity (mrq) | 80.26 EUR |
Current Ratio (mrq) | 1.731 |
Book Value Per Share (mrq) | 44.506 |
Cash Flow Statement
Operating Cash Flow (ttm) | 2.87B EUR |
Levered Free Cash Flow (ttm) | 1.85B EUR |
Profile of Stryker Corporation
Country | Germany |
State | MI |
City | Kalamazoo |
Address | 2825 Airview Boulevard |
ZIP | 49002 |
Phone | 269 385 2600 |
Website | https://www.stryker.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 51000 |
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Q&A For Stryker Corporation Stock
What is a current SYK.F stock price?
Stryker Corporation SYK.F stock price today per share is 321.8 EUR.
How to purchase Stryker Corporation stock?
You can buy SYK.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Stryker Corporation?
The stock symbol or ticker of Stryker Corporation is SYK.F.
Which industry does the Stryker Corporation company belong to?
The Stryker Corporation industry is Medical Devices.
How many shares does Stryker Corporation have in circulation?
The max supply of Stryker Corporation shares is 380.47M.
What is Stryker Corporation Price to Earnings Ratio (PE Ratio)?
Stryker Corporation PE Ratio is 41.84655400 now.
What was Stryker Corporation earnings per share over the trailing 12 months (TTM)?
Stryker Corporation EPS is 7.69 EUR over the trailing 12 months.
Which sector does the Stryker Corporation company belong to?
The Stryker Corporation sector is Healthcare.